Lucine
Bordeaux
About Lucine
Lucine has the ambition to transform and improve patient’s health. Their main therapeutic area is pain. The product, a digital therapeutic is able to relieve patient’s pain in 5 minutes through active substances allowing an analgesic neurostimulation. Customized, their solution is adapted to each patient thanks to an instantaneous measurement and analysis of the pain by facial, vocal and postural recognition.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $6.6M
- Funding stage: Seed
- Last round: Seed (Nov 2020)
- Website: lucine.fr
- Phone: +33 (0) 6 70 10 25 09
Industries & Categories
Big Data, Biotechnology, Health Care, Information Technology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/lucine-60411 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.